
Exact Sciences
(NASDAQ) EXAS
Exact Sciences Financials at a Glance
Market Cap
$20.03B
Revenue (TTM)
$3.25B
Net Income (TTM)
$207.95M
EPS (TTM)
$-1.10
P/E Ratio
-94.98
Dividend
$0.00
Beta (Volatility)
1.25 (Average)
Dividend
$0.00
Beta (Volatility)
1.25 (Average)
Price
$104.93
Volume
946,113
Open
$104.94
Price
$104.93
Volume
946,113
Open
$104.94
Previous Close
$104.93
Daily Range
$104.90 - $104.98
52-Week Range
$38.81 - $104.98
Dividend
$0.00
Beta (Volatility)
1.25 (Average)
Price
$104.93
Volume
946,113
Open
$104.94
Previous Close
$104.93
Daily Range
$104.90 - $104.98
52-Week Range
$38.81 - $104.98
EXAS News
EXAS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Exact Sciences
Industry
Biotechnology
Sector
Health CareEmployees
7,200
CEO
Kevin T. Conroy
Website
www.exactsciences.comHeadquarters
Madison, WI 53719, US
EXAS Financials
Key Financial Metrics (TTM)
Gross Margin
70%
Operating Margin
-6%
Net Income Margin
-6%
Return on Equity
-9%
Return on Capital
-4%
Return on Assets
-4%
Earnings Yield
-1.05%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$20.03B
Shares Outstanding
190.89M
Volume
946.11K
Short Interest
0.00%
Avg. Volume
2.55M
Financials (TTM)
Gross Profit
$2.26B
Operating Income
$99.08M
EBITDA
$122.50M
Operating Cash Flow
$491.44M
Capital Expenditure
$134.66M
Free Cash Flow
$356.78M
Cash & ST Invst.
$964.71M
Total Debt
$2.52B
Exact Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$878.38M
+23.1%
Gross Profit
$615.83M
+43.5%
Gross Margin
70.11%
N/A
Market Cap
$20.03B
N/A
Market Cap/Employee
$2.90M
N/A
Employees
6,900
N/A
Net Income
$85.95M
+90.1%
EBITDA
$20.33M
+97.5%
Quarterly Fundamentals
Net Cash
$1.56B
+9.2%
Accounts Receivable
$298.65M
+20.0%
Inventory
$166.20M
+2.4%
Long Term Debt
$2.50B
+0.7%
Short Term Debt
$39.29M
-85.8%
Return on Assets
-3.55%
N/A
Return on Invested Capital
-3.84%
N/A
Free Cash Flow
$120.45M
+1020.7%
Operating Cash Flow
$151.69M
+222.3%







